Latest It Compliance News

Page 235 of 264
Mont Royal Resources has voluntarily suspended its shares on the ASX pending a critical announcement about a proposed re-compliance transaction, signaling a pivotal moment for the mining company.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Perpetual Limited has received updated, non-binding proposals from KKR for its Wealth Management and Corporate Trust businesses, but key terms and shareholder proceeds remain uncertain.
Claire Turing
Claire Turing
17 Feb 2025
Pengana International Equities Limited reported a striking 189% increase in net profit for the half-year ended December 31, 2024, alongside an 11% portfolio return and consistent fully franked dividends.
Claire Turing
Claire Turing
17 Feb 2025
Lithium Universe Limited’s Definitive Feasibility Study confirms the economic viability of its Bécancour Lithium Refinery, projecting robust returns even amid subdued lithium prices. The project aims to produce 18,270 tonnes per year of battery-grade lithium carbonate, leveraging proven Jiangsu technology and a counter-cyclical development strategy.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Rox Resources reports compelling assay results from its 35,000m drilling campaign at Youanmi, alongside advancing metallurgical testing and critical infrastructure upgrades, positioning the project firmly on track for its mid-2025 resource update.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Artemis Resources has clarified the permitting status of its Radio Hill processing plant and outlined the regulatory and operational steps required to resume processing activities, while granting Greentech Metals an exclusive option to assess copper ore feasibility.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Triangle Energy reports a missed payment from Pilot Energy related to the Cliff Head project sale, while Pilot continues funding operational costs amid capital raise talks.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Acorn Capital Investment Fund Limited has been suspended from ASX trading due to a delayed periodic report, raising questions about its compliance and investor transparency.
Claire Turing
Claire Turing
17 Feb 2025
Neurizon Therapeutics received FDA guidance on its IND application for NUZ-001, with a single request for additional animal exposure data but no safety concerns flagged. The company is actively addressing the FDA’s request while evaluating impacts on its ALS trial timeline.
Ada Torres
Ada Torres
17 Feb 2025
Bendigo and Adelaide Bank has released its Basel III Pillar 3 disclosures for the year ended December 31, 2024, revealing solid capital adequacy and liquidity positions under APRA regulations. The bank maintains robust buffers amid lending growth and evolving market conditions.
Claire Turing
Claire Turing
17 Feb 2025
GPT Group has confirmed a fully unfranked ordinary dividend of AUD 0.12 per security for the six months ending December 2024, payable on February 28, 2025.
Eva Park
Eva Park
17 Feb 2025
Bendigo and Adelaide Bank has announced a fully franked ordinary dividend of AUD 0.30 per share for the half-year ending December 2024, reinforcing its steady shareholder returns.
Victor Sage
Victor Sage
17 Feb 2025